Skip to main content

Enrollment in the Health Benefits for Immigrant Adults (HBIA) program will be temporarily paused effective July 1, 2023.

Enrollment in the Health Benefits for Immigrant Seniors (HBIS) program will be temporarily paused effective Nov. 6, 2023.

Elizabeth M. Whitehorn, Director

Drugs and Therapeutics (D & T) Committee Drugs Under Review for: September 18, 2013

Drug Name Review Type Class Manufacturer
Abilify Maintena New Drug Initial Review Atypical Antipsychotic Otsuka America
Zubsolv New Drug Initial Review Narcotic Orexo
Tivicay New Drug Initial Review HIV antiretroviral ViiV Healthcare
Linzess New Drug Initial Review Guanylate cyclase-C agonist Forest
Tecfidera New Drug Appeal Multiple Sclerosis Biogen Idec
Avonex PDL Appeal Multiple Sclerosis Biogen Idec
TrueResult/TrueTrack PDL Appeal Diabetes Nipro Diagnostics
Dulera PDL Appeal Inhaled Corticosteroid Merck
Advair Diskus PDL Appeal ICS/LABA GlaxoSmithKline